Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
|Hero|January 28, 2014
MD Training, Specialty Affect Menopause Treatments
Advertisement
New research reveals that treatments for troublesome symptoms of menopause not only are varied across specialties but also differ based on how recently physicians were trained and how much knowledge physicians perceive their patients to have about the condition.
Advertisement
Related to this article
Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.
Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.
Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Jean Cunningham, PharmD, BCPS, explains how ob-gyns can link anxiety, sleep disruption, and cognitive changes to perimenopause—and catch it earlier.
Marla Shapiro, MDCM, explains how OPTION-VMS actigraphy data corroborated patient-reported sleep improvements with fezolinetant (Veozah) as early as week 4.
Soma Mandal, MD, is launching “Mind, Body, & the Pause: the Perimenopause and Beyond Series” on Contemporary OB/GYN, featuring specialists from across Hackensack Meridian Health.
Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Evident ovarian cancer screening test: What SOARA will measure
2
FDA approves pritelivir tablets to treat lesions from HSV
3
Anti-CGRP antibodies associated with higher spontaneous abortion risk
4
Wen Shen, MD, on steering patients to evidence-based menopause care
5